Mingjun Wang

Shenzhen, 518111, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy.

TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy.

Journal: Vaccines
Published: July 03, 2025

CAR-T cell therapy based on a TCR mimic nanobody targeting an intracellular antigen for solid cancers.

CAR-T cell therapy based on a TCR mimic nanobody targeting an intracellular antigen for solid cancers.

Journal: Molecular therapy. Oncology
Published: March 05, 2025

Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment.

Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment.

Journal: Frontiers in immunology
Published: July 09, 2023

Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19.

Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19.

Journal: International immunopharmacology
Published: July 27, 2022

Rapid identification of tumor-reactive T-cell receptors by RNA preamplification-based single-cell sequencing.

Rapid identification of tumor-reactive T-cell receptors by RNA preamplification-based single-cell sequencing.

Journal: Journal of immunological methods
Published: February 21, 2022

Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma.

Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma.

Journal: Frontiers in genetics
Published: November 15, 2021

A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy.

A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy.

Journal: Frontiers in immunology
Published: July 21, 2021

An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.

An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.

Journal: BMC immunology
Published: May 24, 2021

Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.

Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.

Journal: The Journal of infectious diseases
Published: April 14, 2021

Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers.

Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers.

Journal: Immunology letters
Published: June 14, 2019

Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.

Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.

Journal: HLA
Published: November 08, 2018

Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report.

Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report.

Journal: Oncology letters
Published: February 13, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026